Health Care
Commentary
President Biden’s Bipartisan Opportunity to Reduce Patients’ Drug Costs
BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures to patients. Consider that ...
Coronavirus
Dr. Henry Miller Featured in Kaiser Health News on AstraZeneca Vaccine
Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America By Sarah Jane Tribble The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting ...
Commentary
Don’t Overreact to Rising Health Spending
U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more ...
Health Care
Orange County Register Ed Board Quotes PRI’s Sally C. Pipes
Not that any of us needed additional reminders, but Californians in the past year have seen the stark limits of government power as state bureaucracies mishandle their most fundamental responsibilities. We’re all still reeling from the Newsom administration’s contradictory responses to COVID-19. Meanwhile, the state Employment Development Department struggles to ...
Commentary
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
There’s a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in the U.K. have been ...
Commentary
The 340B Prescription-Drug Swindle Has Gone on Long Enough
In a hearing on Tuesday, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services. Becerra dismissed the need to reform the federal “340B” program, even though it has morphed from a good-faith effort to help low-income Americans access medicines ...
Health Care
Healthcare Policy During COVID-19 – Sacramento Policy Conference
This podcast is a recording of the health care panel discussion at PRI’s virtual Sacramento Policy Conference. Our All-Star panelists include Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy; Wayne Winegarden, PRI senior fellow in business and economics and director of PRI’s Center for ...
Commentary
Biden’s plan to subsidize COBRA is a waste of money
President Biden has repeatedly promised to build a fairer economy, one that “works for everyone.” But if his stimulus plan is any indication, the president has a funny definition of fairness. His $1.9 trillion proposal would force working-class Americans to cover health insurance premiums for people who have lost their ...
California
Xavier Becerra confirmation would be a dream come true for single-payer advocates
Tomorrow, California Attorney General Xavier Becerra will appear before the Senate for his confirmation hearing as President Biden’s pick to lead the Department of Health and Human Services. If Becerra’s career in public office is any indication, he’ll do everything in his power to exert greater government control over our ...
Coronavirus
Dr. Henry Miller Featured on Fox News, “What happened to coronavirus, flu ‘twin-demic’? Experts weigh in”
What happened to coronavirus, flu ‘twin-demic’? Experts weigh in By Alexandria Hein With coronavirus cases soaring in late summer, experts warned about the potential for a so-called “twin-demic,” which they said would’ve seen hospital systems overwhelmed by both COVID-19 and the influx of flu patients, but the surge never came. In fact, the Centers for ...
President Biden’s Bipartisan Opportunity to Reduce Patients’ Drug Costs
BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures to patients. Consider that ...
Dr. Henry Miller Featured in Kaiser Health News on AstraZeneca Vaccine
Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America By Sarah Jane Tribble The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting ...
Don’t Overreact to Rising Health Spending
U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more ...
Orange County Register Ed Board Quotes PRI’s Sally C. Pipes
Not that any of us needed additional reminders, but Californians in the past year have seen the stark limits of government power as state bureaucracies mishandle their most fundamental responsibilities. We’re all still reeling from the Newsom administration’s contradictory responses to COVID-19. Meanwhile, the state Employment Development Department struggles to ...
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
There’s a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in the U.K. have been ...
The 340B Prescription-Drug Swindle Has Gone on Long Enough
In a hearing on Tuesday, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services. Becerra dismissed the need to reform the federal “340B” program, even though it has morphed from a good-faith effort to help low-income Americans access medicines ...
Healthcare Policy During COVID-19 – Sacramento Policy Conference
This podcast is a recording of the health care panel discussion at PRI’s virtual Sacramento Policy Conference. Our All-Star panelists include Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy; Wayne Winegarden, PRI senior fellow in business and economics and director of PRI’s Center for ...
Biden’s plan to subsidize COBRA is a waste of money
President Biden has repeatedly promised to build a fairer economy, one that “works for everyone.” But if his stimulus plan is any indication, the president has a funny definition of fairness. His $1.9 trillion proposal would force working-class Americans to cover health insurance premiums for people who have lost their ...
Xavier Becerra confirmation would be a dream come true for single-payer advocates
Tomorrow, California Attorney General Xavier Becerra will appear before the Senate for his confirmation hearing as President Biden’s pick to lead the Department of Health and Human Services. If Becerra’s career in public office is any indication, he’ll do everything in his power to exert greater government control over our ...
Dr. Henry Miller Featured on Fox News, “What happened to coronavirus, flu ‘twin-demic’? Experts weigh in”
What happened to coronavirus, flu ‘twin-demic’? Experts weigh in By Alexandria Hein With coronavirus cases soaring in late summer, experts warned about the potential for a so-called “twin-demic,” which they said would’ve seen hospital systems overwhelmed by both COVID-19 and the influx of flu patients, but the surge never came. In fact, the Centers for ...
